Ubs Group Ag Neuro Sense Therapeutics Ltd. Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

A detailed history of Ubs Group Ag transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 11,928 shares of NRSN stock, worth $10,138. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,928
Previous 5,496 117.03%
Holding current value
$10,138
Previous $4,000 425.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.78 - $2.11 $5,016 - $13,571
6,432 Added 117.03%
11,928 $21,000
Q4 2023

Feb 09, 2024
SELL
$0.44 - $1.49 $1,834 - $6,211
-4,169 Reduced 43.14%
5,496 $4,000
Q3 2023

Nov 09, 2023
BUY
$0.71 - $1.47 $6,862 - $14,207
9,665 New
9,665 $6,000
Q1 2023

May 12, 2023
BUY
$1.2 - $2.22 $836 - $1,547
697 Added 17.15%
4,762 $8,000
Q4 2022

Feb 08, 2023
BUY
$1.22 - $1.9 $2,730 - $4,252
2,238 Added 122.5%
4,065 $4,000
Q3 2022

Nov 10, 2022
SELL
N/A
-11,601 Reduced 86.39%
1,827 $3,000
Q2 2022

Aug 10, 2022
BUY
N/A
11,544 Added 612.74%
13,428 $45,000
Q1 2022

May 16, 2022
SELL
N/A
-6,134 Reduced 76.5%
1,884 $7,000
Q4 2021

Feb 14, 2022
BUY
N/A
8,018 New
8,018 $20,000

Others Institutions Holding NRSN

# of Institutions
9
Shares Held
167K
Call Options Held
0
Put Options Held
0
View Full List

About NeuroSense Therapeutics Ltd.

NRSN Quotes by TradingView
  • Ticker NRSN
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,674,000
  • Market Cap $9.92M
More about NRSN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email